ClinicalTrials.Veeva

Menu

A Novel MSE Score to Predict rHCC Patients

T

Tongji Hospital

Status

Completed

Conditions

HCC

Treatments

Procedure: hepatectomy

Study type

Observational

Funder types

Other

Identifiers

NCT05450874
2019CFB433

Details and patient eligibility

About

Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

Enrollment

300 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a diagnosis of ruptured tumor confirmed by enhanced computed tomography (CT) and/or abdominal magnetic resonance imaging (MRI),
  • a diagnosis of HCC made by two experienced pathologists

Exclusion criteria

  • extrahepatic HCC metastasis
  • death within 1 month after surgery

Trial design

300 participants in 2 patient groups

Training cohort
Treatment:
Procedure: hepatectomy
Validation cohort
Treatment:
Procedure: hepatectomy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems